Literature DB >> 30476002

Spastic paraplegia due to SPAST mutations is modified by the underlying mutation and sex.

Livia Parodi1, Silvia Fenu1, Mathieu Barbier1, Guillaume Banneau1, Charles Duyckaerts1,2, Sophie Tezenas du Montcel3,4, Marie-Lorraine Monin1, Samia Ait Said1, Justine Guegan1, Chantal M E Tallaksen1,5,6, Bertrand Sablonniere7,8, Alexis Brice1, Giovanni Stevanin1,9, Christel Depienne1,10, Alexandra Durr1.   

Abstract

Hereditary spastic paraplegias (HSPs) are rare neurological disorders caused by progressive distal degeneration of the corticospinal tracts. Among the 79 loci and 65 spastic paraplegia genes (SPGs) involved in HSPs, mutations in SPAST, which encodes spastin, responsible for SPG4, are the most frequent cause of both familial and sporadic HSP. SPG4 is characterized by a clinically pure phenotype associated with restricted involvement of the corticospinal tracts and posterior columns of the spinal cord. It is rarely associated with additional neurological signs. However, both age of onset and severity of the disorder are extremely variable. Such variability is both intra- and inter-familial and may suggest incomplete penetrance, with some patients carrying mutations remaining asymptomatic for their entire life. We analysed a cohort of 842 patients with SPG4-HSP to assess genotype-phenotype correlations. Most patients were French (89%) and had a family history of SPG4-HSP (75%). Age at onset was characterized by a bimodal distribution, with high inter-familial and intra-familial variability, especially concerning first-degree relatives. Penetrance of the disorder was 0.9, complete after 70 years of age. Penetrance was lower in females (0.88 versus 0.94 in males, P = 0.01), despite a more diffuse phenotype with more frequent upper limb involvement. Seventy-seven per cent of pathogenic mutations (missense, frameshift, splice site, nonsense, and deletions) were located in the AAA cassette of spastin, impairing its microtubule-severing activity. A comparison of the missense and truncating mutations revealed a significantly lower age at onset for patients carrying missense mutations than those carrying truncating mutations, explaining the bimodal distribution of the age at onset. The age at onset for patients carrying missense mutations was often before 10 years, sometimes associated with intellectual deficiency. Neuropathological examination of a single case showed degeneration of the spinocerebellar and spinocortical tracts, as well as the posterior columns. However, there were numerous small-diameter processes among unusually large myelinated fibres in the corticospinal tract, suggesting marked regeneration. In conclusion, this large cohort of 842 individuals allowed us to identify a significantly younger age at onset in missense mutation carriers and lower penetrance in females, despite a more severe disorder. Neuropathology in one case showed numerous small fibres suggesting regeneration.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30476002     DOI: 10.1093/brain/awy285

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  14 in total

1.  A p.Glu420Gln mutation in SPAST is associated with infantile onset spastic paraplegia complicated by cerebella ataxia, epilepsy, peripheral neuropathy, and hypoplasia of the corpus callosum.

Authors:  Haitian Nan; Tomoko Mizuno; Atsuko Arisaka; Kenshi Sei; Yoshihisa Takiyama
Journal:  Neurol Sci       Date:  2022-01-12       Impact factor: 3.307

2.  Evidence of mosaicism in SPAST variant carriers in four French families.

Authors:  Chloé Angelini; Cyril Goizet; Samia Ait Said; William Camu; Christel Depienne; Bénédicte Heron; Bophara Kol; Marine Guillaud-Bataille; Perrine Pennamen; Caroline Rooryck; Clarisse Scherer-Gagou; Laurène Tissier; Giovanni Stevanin; Eric Leguern; Guillaume Banneau
Journal:  Eur J Hum Genet       Date:  2021-05-06       Impact factor: 5.351

3.  Clinical Characterization of 2 Siblings with a Homozygous SPAST Variant.

Authors:  Héctor Cruz-Camino; Mercedes Vázquez-Cantú; Diana Laura Vázquez-Cantú; Jesús Santos-Guzmán; Antonio Bandala-Jacques; René Gómez-Gutiérrez; Consuelo Cantú-Reyna
Journal:  Am J Case Rep       Date:  2020-05-11

4.  A Japanese SPG4 Patient with a Confirmed De Novo Mutation of the SPAST Gene.

Authors:  Haitian Nan; Kensho Okamoto; Lihua Gao; Yuto Morishima; Yuta Ichinose; Kishin Koh; Masaki Hashiyada; Noboru Adachi; Yoshihisa Takiyama
Journal:  Intern Med       Date:  2020-06-09       Impact factor: 1.271

Review 5.  Insights From Genetic Studies of Cerebral Palsy.

Authors:  Sara A Lewis; Sheetal Shetty; Bryce A Wilson; Aris J Huang; Sheng Chih Jin; Hayley Smithers-Sheedy; Michael C Fahey; Michael C Kruer
Journal:  Front Neurol       Date:  2021-01-21       Impact factor: 4.003

Review 6.  Recent advances in understanding hereditary spastic paraplegias and emerging therapies.

Authors:  Pauline Lallemant-Dudek; Frederic Darios; Alexandra Durr
Journal:  Fac Rev       Date:  2021-03-10

7.  De novo pathogenic variant in SETX causes a rapidly progressive neurodegenerative disorder of early childhood-onset with severe axonal polyneuropathy.

Authors:  Aristides Hadjinicolaou; Kathie J Ngo; Daniel Y Conway; John P Provias; Steven K Baker; Lauren I Brady; Craig L Bennett; Albert R La Spada; Brent L Fogel; Grace Yoon
Journal:  Acta Neuropathol Commun       Date:  2021-12-18       Impact factor: 7.801

8.  Clinical and molecular characterization of a large cohort of childhood onset hereditary spastic paraplegias.

Authors:  Gabriela Marchisio Giordani; Fabrício Diniz; Helena Fussiger; Carelis Gonzalez-Salazar; Karina Carvalho Donis; Fernando Freua; Roberta Paiva Magalhães Ortega; Julian Letícia de Freitas; Orlando Graziani Povoas Barsottini; Sergio Rosemberg; Fernando Kok; José Luiz Pedroso; Marcondes Cavalcante França; Jonas Alex Morales Saute
Journal:  Sci Rep       Date:  2021-11-15       Impact factor: 4.379

Review 9.  Insights into Clinical, Genetic, and Pathological Aspects of Hereditary Spastic Paraplegias: A Comprehensive Overview.

Authors:  Liena E O Elsayed; Isra Zuhair Eltazi; Ammar E Ahmed; Giovanni Stevanin
Journal:  Front Mol Biosci       Date:  2021-11-26

10.  Mutations disrupting neuritogenesis genes confer risk for cerebral palsy.

Authors:  Sheng Chih Jin; Sara A Lewis; Somayeh Bakhtiari; Xue Zeng; Michael C Sierant; Sheetal Shetty; Sandra M Nordlie; Aureliane Elie; Mark A Corbett; Bethany Y Norton; Clare L van Eyk; Shozeb Haider; Brandon S Guida; Helen Magee; James Liu; Stephen Pastore; John B Vincent; Janice Brunstrom-Hernandez; Antigone Papavasileiou; Michael C Fahey; Jesia G Berry; Kelly Harper; Chongchen Zhou; Junhui Zhang; Boyang Li; Hongyu Zhao; Jennifer Heim; Dani L Webber; Mahalia S B Frank; Lei Xia; Yiran Xu; Dengna Zhu; Bohao Zhang; Amar H Sheth; James R Knight; Christopher Castaldi; Irina R Tikhonova; Francesc López-Giráldez; Boris Keren; Sandra Whalen; Julien Buratti; Diane Doummar; Megan Cho; Kyle Retterer; Francisca Millan; Yangong Wang; Jeff L Waugh; Lance Rodan; Julie S Cohen; Ali Fatemi; Angela E Lin; John P Phillips; Timothy Feyma; Suzanna C MacLennan; Spencer Vaughan; Kylie E Crompton; Susan M Reid; Dinah S Reddihough; Qing Shang; Chao Gao; Iona Novak; Nadia Badawi; Yana A Wilson; Sarah J McIntyre; Shrikant M Mane; Xiaoyang Wang; David J Amor; Daniela C Zarnescu; Qiongshi Lu; Qinghe Xing; Changlian Zhu; Kaya Bilguvar; Sergio Padilla-Lopez; Richard P Lifton; Jozef Gecz; Alastair H MacLennan; Michael C Kruer
Journal:  Nat Genet       Date:  2020-09-28       Impact factor: 41.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.